From Sino Biological Inc. May 20 2026 Sino Biological, Inc., a global leader in recombinant technology, is proud to announce the launch of its innovative XPressMAX ™ Cell-Free Protein Synthesis Kit (Cat#: CFKIT02) , a cutting-edge solution designed to supercharge artificial intelligence (AI)-driven high-throughput screening pipelines for antibody drug discovery. Image Credit: Sino Biological Inc. XPressMAX ™ Cell-Free Protein Synthesis Kit The novel kit leverages advanced cell-free protein